John K. Chan

20.2k citations
281 papers · 12.1k · 6 hit papers · h-index 60

Impact in

Papers in

    • Ovarian cancer diagnosis and treatment 89
    • PARP inhibition in cancer therapy 24
    • Viral-associated cancers and disorders 13

John K. Chan

265 papers receiving 11.8k citations

John K. Chan's Hit Papers

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial 2019 · 390 citations
3900+7+15Years since publication100200300400500

Peers

John K. Chan
Comparison fields: 5 of 140
  • Reproductive Medicine 3.6k
  • Obstetrics and Gynecology 2.9k
  • Oncology 3.1k
  • Pathology and Forensic Medicine 1.1k
  • Endocrinology, Diabetes and Metabolism 970
Replace Steven G. Silverberg with:
Steven G. Silverberg United States
William T. Creasman United States
Sandro Pignata Italy
Philip J. DiSaia United States
Angiolo Gadducci Italy
Brian N. Bundy United States
Carien L. Creutzberg Netherlands
Sërgio Pecorelli Italy
Karl C. Podratz United States
Martee L. Hensley United States
John K. Chan relative to Steven G. Silverberg United States Steven G. Silverberg's profile →
Citations per field
00.5×10×
Steven G. Silverberg · 1×
Citations per year

Countries citing papers authored by John K. Chan

Since Specialization
Citations

This map shows the geographic impact of John K. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John K. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John K. Chan more than expected).

Fields of papers citing papers by John K. Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John K. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John K. Chan. The network helps show where John K. Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside John K. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John K. Chan Line = papers co-authored together John K. Chan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 281 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
Hit paper breakdown →
2003573
2
Inherited Mutations in Women With Ovarian Carcinoma
Hit paper breakdown →
2015517
3
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
Hit paper breakdown →
2006486
4
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
Hit paper breakdown →
2017412
5
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
Hit paper breakdown →
2019390
6 2008346
7 2006316
8
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
Hit paper breakdown →
2016253
9 1997244
10 2008238
11 2008236
12 2015204
13 2006196
14 2015190
15 2001173
16 2008170
17 2010169
18 2008164
19 2007162
20 2003150

About John K. Chan

John K. Chan is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Pathology and Forensic Medicine and Epidemiology, having authored 281 papers that have together received 12.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (89 papers), Endometrial and Cervical Cancer Treatments (59 papers), PARP inhibition in cancer therapy (24 papers), Cervical Cancer and HPV Research (15 papers), Lymphoma Diagnosis and Treatment (14 papers), Viral-associated cancers and disorders (13 papers), Uterine Myomas and Treatments (9 papers) and BRCA gene mutations in cancer (8 papers). The work is most often cited by research in Reproductive Medicine (3.6k citations), Obstetrics and Gynecology (2.9k citations), Oncology (3.1k citations), Pathology and Forensic Medicine (1.1k citations) and Endocrinology, Diabetes and Metabolism (970 citations). John K. Chan has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Daniel S. Kapp, Kathryn Osann, Jacob Y. Shin, Bradley J. Monk, Michael K. Cheung, Jonathan S. Berek, Amreen Husain, Nelson N.H. Teng, Wah Cheuk and William Y.W. Tsang. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, Obstetrics and Gynecology, The American Journal of Surgical Pathology and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact